This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Abnormal blood-pressure reading, without diagnosis
R18_ABNORMAL_BLOOD_P_READI_WO_DIAGNOSIS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1809 |
4. Check minimum number of eventsNone |
1809 |
5. Include endpointsNone |
1809 |
6. Filter based on genotype QC (FinnGen only) |
1809 |
Control definitions (FinnGen only)
- Control exclude
- R18_SYMPTOMS_SIGNS_INVOLVI_CIRCULATO_RESPI_SYSTEMS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R0
- Name in latin
- Mensura pressionis sanguineae abnormis sine diagnosi
Similar endpoints
↥List of similar endpoints to
Abnormal blood-pressure reading, without diagnosis
based on the number of shared cases.
Similar with more cases:
- Symptoms and signs involving the circulatory and respiratory systems
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1809 | 1190 | 619 |
| Unadjusted period prevalence (%) | 0.36 | 0.41 | 0.27 |
| Median age at first event (years) | 57.39 | 58.20 | 55.84 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1581
- Matched controls
- 15808
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R03.0
ICD-10 Finland
Elevated blood-pressure reading, without diagnosis of hypertension
570.5
323.0
1433
260
R07.4
ICD-10 Finland
Chest pain, unspecified
9.2
188.5
436
629
C08CA01
ATC
amlodipine; oral
3.7
119.2
722
2917
R06.0
ICD-10 Finland
Dyspnoea
5.8
109.8
347
728
R03.1
ICD-10 Finland
Nonspecific low blood-pressure reading
147.4
92.1
97
7
I10
ICD-10 Finland
Essential (primary) hypertension
2.8
84.4
961
5579
R51.80
ICD-10 Finland
Headache
3.7
60.9
304
960
R42
ICD-10 Finland
Dizziness and giddiness
3.0
56.1
388
1550
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
52.8
639
3501
C07AB07
ATC
bisoprolol; oral
2.3
50.9
674
3843
R00.2
ICD-10 Finland
Palpitations
6.5
50.0
137
229
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
4.1
49.7
214
588
R03
ICD-10 Finland
Abnormal blood-pressure reading, without diagnosis
22.1
49.1
72
34
R07.3
ICD-10 Finland
Other chest pain
5.7
45.3
136
255
K85
ICPC
Elevated blood pressure
2.9
43.5
295
1143
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.8
40.9
303
1237
R53
ICD-10 Finland
Malaise and fatigue
2.6
40.0
329
1428
A02BC02
ATC
pantoprazole; systemic
2.0
39.5
967
6905
R06.5
ICD-10 Finland
Mouth breathing
8.9
35.6
77
90
R03AC02
ATC
salbutamol; inhalant
2.0
34.8
752
5014
R04.0
ICD-10 Finland
Epistaxis
8.2
33.8
77
98
AA1AD
NOMESCO Finland
CT of head and brain
2.3
32.7
353
1748
R05
ICD-10 Finland
Cough
2.7
32.1
247
1020
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
31.4
524
3132
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
29.3
400
2189
R00.0
ICD-10 Finland
Tachycardia, unspecified
7.7
28.8
68
92
G44.2
ICD-10 Finland
Tension-type headache
2.7
28.4
217
889
C09CA01
ATC
losartan; oral
2.1
27.7
369
1993
C09CA06
ATC
candesartan; oral
2.2
27.1
334
1740
R06.4
ICD-10 Finland
Hyperventilation
73.9
25.8
29
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.5
25.8
221
962
XF602
NOMESCO Finland
Bloodpressure monitoring
12.1
25.8
47
40
K30
ICD-10 Finland
Functional dyspepsia
2.9
25.7
170
636
I15.9
ICD-10 Finland
Secondary hypertension, unspecified
16.0
24.2
39
25
XF402
NOMESCO Finland
ECG with work load test
3.3
23.9
127
409
G47.3
ICD-10 Finland
Sleep apnoea
2.2
23.2
251
1228
A02BC05
ATC
esomeprazole; systemic
1.8
23.0
558
3707
XF404
NOMESCO Finland
Ambulatory ECG
3.2
22.8
126
418
C07AA05
ATC
propranolol; systemic
2.0
22.0
306
1665
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
21.9
628
4378
N02AX02
ATC
tramadol; systemic, rectal
1.7
21.8
566
3828
J01AA02
ATC
doxycycline; systemic
1.7
21.7
1133
9376
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.2
21.5
235
1148
A11
ICPC
Chest pain NOS
3.4
21.5
106
323
J45.9
ICD-10 Finland
Asthma, unspecified
2.3
21.3
223
1072
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
20.0
318
1817
R04.2
ICD-10 Finland
Haemoptysis
16.6
19.7
31
19
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.7
19.6
139
543
Z71.8
ICD-10 Finland
Other specified counselling
1.9
19.1
343
2040
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.8
19.0
127
476
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.4
18.2
90
275
N17
ICPC
Vertigo/dizziness
2.4
18.1
162
717
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
17.7
229
1200
XF600
NOMESCO Finland
Bloodpressure measurement
3.1
17.2
98
332
K80
ICPC
Cardiac arrhythmia NOS
2.8
17.0
113
425
R00.1
ICD-10 Finland
Bradycardia, unspecified
11.3
16.8
31
28
R05
ICPC
Cough
1.8
16.7
313
1879
R55
ICD-10 Finland
Syncope and collapse
2.5
16.6
139
593
A02BC03
ATC
lansoprazole; oral
1.7
16.5
386
2488
M79.6
ICD-10 Finland
Pain in limb
1.6
16.4
489
3380
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
16.3
227
1222
R20.2
ICD-10 Finland
Paraesthesia of skin
2.8
16.2
104
382
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
16.1
194
985
N05BA04
ATC
oxazepam; oral
1.8
16.1
338
2102
N03AX12
ATC
gabapentin; oral
2.1
16.0
203
1055
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
15.9
277
1623
M03BX02
ATC
tizanidine; oral
1.5
15.7
879
7074
H02AB06
ATC
prednisolone; systemic
1.6
15.5
606
4472
R03BA05
ATC
fluticasone; inhalant
1.9
15.3
241
1361
UJF32
NOMESCO Finland
Coloscopy
1.8
15.1
319
1983
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.0
15.1
197
1036
M54.5
ICD-10 Finland
Low back pain
1.6
15.1
443
3034
J01DB01
ATC
cefalexin; oral
1.6
15.0
1186
10305
C09AA05
ATC
ramipril; oral
1.8
15.0
299
1829
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
14.8
180
915
A04
ICPC
Weakness/tiredness general
2.1
14.8
174
874
D01
ICPC
Abdominal pain/cramps general
2.2
14.8
158
759
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.1
14.7
182
935
R01AD09
ATC
mometasone; nasal
1.6
14.7
614
4586
N05AH04
ATC
quetiapine; oral
1.9
14.7
222
1234
P01AB01
ATC
metronidazole; oral, rectal
1.6
14.6
555
4049
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.4
14.5
127
557
R02
ICPC
Shortness of breath/dyspnoea
2.3
14.4
141
652
N06AX11
ATC
mirtazapine; oral
1.6
14.2
416
2837
I49.3
ICD-10 Finland
Ventricular premature depolarization
3.0
14.2
84
294
O13
ICD-10 Finland
Gestational [pregnancy-induced] hypertension
3.3
14.1
71
221
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
14.0
236
1360
N03AX16
ATC
pregabalin; oral
1.7
13.9
299
1864
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
5.6
13.9
40
73
R12
ICD-10 Finland
Heartburn
2.5
13.9
108
444
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
13.7
1016
8577
L03
ICPC
Low back symptom/complaint
1.7
13.6
329
2129
N02BE01
ATC
paracetamol; systemic, rectal
1.6
13.5
1248
11074
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
13.4
562
4177
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
13.2
305
1940
R07.2
ICD-10 Finland
Precordial pain
10.6
13.2
25
24
L04
ICPC
Chest symptom/complaint
2.8
13.1
84
308
C08CA13
ATC
lercanidipine; oral
2.0
13.0
165
852
R31
ICD-10 Finland
Unspecified haematuria
2.4
12.8
113
499
M79.1
ICD-10 Finland
Myalgia
2.0
12.7
173
920
XQ800
NOMESCO Finland
Prick test
2.5
12.7
104
440
I47.1
ICD-10 Finland
Supraventricular tachycardia
3.4
12.7
62
190
WX110
NOMESCO Finland
Local anesthesy
1.5
12.5
990
8387
SPAT1263
SPAT
Sampling
1.5
12.5
572
4321
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
12.4
315
2057
M54.4
ICD-10 Finland
Lumbago with sciatica
1.8
12.1
205
1185
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.2
12.0
125
594
R74
ICPC
Upper respiratory infection acute
1.6
11.8
395
2767
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.5
11.8
95
399
I49.1
ICD-10 Finland
Atrial premature depolarization
3.9
11.8
48
127
K59.09
ICD-10 Finland
Constipation, unspecified
2.7
11.8
78
294
SPAT1097
SPAT
Recording of ECG
1.9
11.7
181
1011
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
11.6
252
1573
L01
ICPC
Neck symptom/complaint
1.8
11.6
192
1099
A02BC01
ATC
omeprazole; systemic
1.6
11.6
331
2230
F51.0
ICD-10 Finland
Nonorganic insomnia
1.9
11.5
180
1009
F29
ICPC
Eye symptom/complaint other
2.2
11.4
121
579
A01
ICPC
Pain general/multiple sites
2.3
11.4
102
453
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
11.4
254
1598
R21
ICPC
Throat symptom/complaint
1.7
11.3
272
1743
J01MA02
ATC
ciprofloxacin; systemic
1.5
11.3
475
3506
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
3.6
11.2
50
143
C07AB02
ATC
metoprolol; systemic
1.7
11.1
222
1351
M54.6
ICD-10 Finland
Pain in thoracic spine
2.5
11.1
88
369
R50.9
ICD-10 Finland
Fever, unspecified
1.9
11.0
171
955
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
10.9
597
4646
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.3
10.8
102
463
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.9
10.8
160
879
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
10.7
287
1893
K04
ICPC
Palpitations/awareness of heart
2.7
10.7
71
267
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
10.7
116
562
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.8
10.7
208
1253
L08
ICPC
Shoulder symptom/complaint
1.7
10.7
243
1536
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
10.6
368
2592
S06.0
ICD-10 Finland
Concussion
2.0
10.6
133
685
J01FA09
ATC
clarithromycin; systemic
1.5
10.6
417
3025
J01CA04
ATC
amoxicillin; systemic
1.5
10.6
1168
10386
J01FF01
ATC
clindamycin; systemic
1.6
10.5
342
2375
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.3
10.4
100
459
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
10.4
238
1505
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
10.3
753
6179
R07.0
ICD-10 Finland
Pain in throat
2.7
10.2
69
264
R03BA02
ATC
budesonide; inhalant
1.7
10.2
204
1239
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
10.0
689
5574
R96
ICPC
Asthma
2.2
10.0
104
495
R06AX27
ATC
desloratadine; oral
1.5
10.0
359
2546
R11
ICD-10 Finland
Nausea and vomiting
2.2
10.0
100
471
J01FA06
ATC
roxithromycin; oral
1.5
9.9
511
3912
R5140
NOMESCO Finland
Monitoring the use of the aid
2.1
9.9
106
514
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
9.8
165
947
N05CF01
ATC
zopiclone; oral
1.5
9.8
403
2939
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.8
9.8
163
935
F41.09
ICD-10 Finland
UNS Panic Syndrome
3.5
9.8
44
128
A02BA02
ATC
ranitidine; systemic
1.7
9.8
231
1471
UDC00
NOMESCO Finland
Ear microscopy
2.2
9.7
93
428
R01AD12
ATC
fluticasone furoate; nasal
1.5
9.7
374
2695
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.9
9.7
134
720
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
9.6
154
870
A29
ICPC
General symptom/complaint other
1.9
9.6
139
758
I95.9
ICD-10 Finland
Hypotension, unspecified
6.4
9.6
24
38
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
9.5
469
3549
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
9.5
370
2667
D02
ICPC
Abdominal pain epigastric
2.4
9.5
80
344
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
9.5
134
724
R06AE07
ATC
cetirizine; oral
1.4
9.4
580
4585
J01FA10
ATC
azithromycin; systemic
1.4
9.4
797
6669
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.8
9.4
57
206
S29
ICPC
Skin symptom/complaint other
1.7
9.3
215
1360
R03BA08
ATC
ciclesonide; inhalant
2.2
9.3
92
430
H92.0
ICD-10 Finland
Otalgia
2.4
9.2
76
327
R29
ICPC
Respiratory symptom/complaint other
2.3
9.1
81
361
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.1
9.1
102
502
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
9.1
725
5991
N01
ICPC
Headache
1.9
9.0
131
715
P06
ICPC
Sleep disturbance
2.0
9.0
121
644
R51
ICD-10 Finland
Headache
2.6
9.0
65
260
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
2.0
9.0
119
630
SPAT1312
SPAT
General health counselling
1.5
9.0
420
3140
R03DC03
ATC
montelukast; oral
1.7
8.9
184
1129
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.9
8.8
135
751
Z00.0
ICD-10 Finland
General medical examination
1.6
8.8
240
1587
Z3231
NOMESCO Finland
Registered nurse
1.5
8.8
335
2396
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.6
8.8
60
232
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.0
8.7
104
525
D12
ICPC
Constipation
3.1
8.7
45
146
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.2
8.7
43
135
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.0
8.6
104
530
U02
ICPC
Urinary frequency/urgency
1.7
8.6
170
1027
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
2.8
8.6
55
204
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
8.6
355
2586
D11
ICPC
Diarrhoea
1.8
8.6
144
828
I49.8
ICD-10 Finland
Other specified cardiac arrhythmias
3.4
8.4
39
117
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
8.4
124
681
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
8.4
116
623
R03AC03
ATC
terbutaline; inhalant
1.7
8.3
164
991
J01MA14
ATC
moxifloxacin; systemic
2.0
8.3
99
500
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.0
8.3
103
532
O10.0
ICD-10 Finland
Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium
4.4
8.2
28
64
M25.5
ICD-10 Finland
Pain in joint
1.5
8.2
357
2625
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.6
8.2
255
1740
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.7
8.1
169
1039
L02
ICPC
Back symptom/complaint
1.9
8.1
116
630
I15.0
ICD-10 Finland
Renovascular hypertension
17.3
8.1
12
7
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
11.8
8.1
14
12
UKC02
NOMESCO Finland
Cystoscopy
1.7
8.1
163
992
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.9
8.0
115
624
XG410
NOMESCO Finland
Flow-volume spirometry
3.3
8.0
39
122
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
8.0
202
1310
N03AE01
ATC
clonazepam; systemic
2.3
8.0
71
317
ZXE00
NOMESCO Finland
One hour or less
1.4
8.0
507
4001
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.8
8.0
139
810
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.1
8.0
85
410
J45.1
ICD-10 Finland
Nonallergic asthma
2.3
8.0
70
309
J01MA12
ATC
levofloxacin; systemic
1.6
8.0
203
1321
B01AC04
ATC
clopidogrel; oral
1.8
7.9
138
804
C10AA05
ATC
atorvastatin; oral
1.4
7.9
410
3118
SPAT1301
SPAT
No procedures
1.4
7.8
391
2948
N05AH03
ATC
olanzapine; systemic
2.1
7.8
82
393
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
4.3
7.8
27
63
E66.8
ICD-10 Finland
Other obesity
2.3
7.8
67
294
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
7.8
186
1186
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.0
7.8
97
499
ZYC01
NOMESCO Finland
Remote contact by phone
2.5
7.8
60
247
WX892
NOMESCO Finland
Monitored bed care
2.2
7.8
79
373
J20
ICD-10 Finland
Acute bronchitis
1.9
7.8
111
602
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
7.8
385
2900
C03CA01
ATC
furosemide; systemic
1.5
7.8
257
1779
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
7.8
147
878
I95.1
ICD-10 Finland
Orthostatic hypotension
3.4
7.8
36
109
K59.0
ICD-10 Finland
Constipation
2.4
7.7
64
277
N30.0
ICD-10 Finland
Acute cystitis
1.7
7.7
165
1023
R06.2
ICD-10 Finland
Wheezing
4.6
7.7
25
55
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
7.7
465
3636
R03BA01
ATC
beclometasone; inhalant
1.7
7.6
154
936
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
7.6
121
684
K02.1
ICD-10 Finland
Caries of dentine
1.3
7.6
766
6506
H02AB04
ATC
methylprednisolone; systemic
1.7
7.6
173
1093
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.7
7.6
150
908
R01.0
ICD-10 Finland
Benign and innocent cardiac murmurs
8.9
7.5
15
17
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.2
7.5
73
342
N06AB10
ATC
escitalopram; oral
1.5
7.4
245
1693
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
7.4
144
866
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.6
7.4
173
1097
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.8
7.4
123
705
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
2.4
7.4
61
264
J45
ICD-10 Finland
Asthma
1.9
7.3
104
565
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
7.3
140
840
M54
ICD-10 Finland
Dorsalgia
1.7
7.3
136
812
C07AB12
ATC
nebivolol; oral
3.0
7.3
39
132
R52.9
ICD-10 Finland
Pain, unspecified
1.9
7.2
97
515
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
2.5
7.2
55
229
WX002
NOMESCO Finland
Sedation and analgesia
1.5
7.2
241
1673
R01AD08
ATC
fluticasone; nasal
1.4
7.2
340
2535
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.7
7.2
132
783
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
7.2
84
424
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
7.2
404
3113
M01AH05
ATC
etoricoxib; oral
1.3
7.1
783
6706
C02AC05
ATC
moxonidine; oral
2.7
7.1
46
173
R09
ICPC
Sinus symptom/complaint
1.9
7.1
100
539
L17
ICPC
Foot/toe symptom/complaint
1.5
7.1
303
2210
XKD00
NOMESCO Finland
Uroflowmetry
1.7
7.1
141
853
R03AK07
ATC
formoterol and budesonide; inhalant
1.6
7.1
213
1438
M47.9
ICD-10 Finland
Spondylosis, unspecified
2.9
7.1
41
144
SPAT1310
SPAT
Counselling related to known health issue
1.4
7.1
403
3108
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
7.1
106
589
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.5
7.1
53
218
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
2.3
7.0
59
258
KMAK
NOMESCO Finland
NA
1.3
6.9
703
5943
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
6.9
510
4102
Z01.9
ICD-10 Finland
Special examination, unspecified
2.2
6.9
66
306
R01AD05
ATC
budesonide; nasal
1.9
6.9
96
517
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.4
6.9
342
2570
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.7
6.9
44
164
D25
ICPC
Abdominal distension
3.8
6.9
27
72
K24
ICPC
Fear of heart disease
3.2
6.9
34
109
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
6.9
209
1420
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.8
6.8
118
683
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.3
6.8
60
267
SPAT1240
SPAT
Therapeutic discussion
1.7
6.8
132
796
E66.01
ICD-10 Finland
Obesity due to excess calories
2.0
6.8
88
463
R60.0
ICD-10 Finland
Localized oedema
1.8
6.8
118
687
G04CA02
ATC
tamsulosin; oral
1.6
6.8
171
1108
DKW00
NOMESCO Finland
Cauterisation of mucosa of nose
40.2
6.8
8
*
R4120
NOMESCO Finland
Occupational therapy
2.0
6.7
85
442
J31.0
ICD-10 Finland
Chronic rhinitis
2.0
6.7
85
442
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
6.7
330
2474
L12
ICPC
Hand/finger symptom/complaint
1.6
6.7
178
1168
N06AX21
ATC
duloxetine; oral
1.7
6.7
122
721
I20.09
ICD-10 Finland
Unstable angina
2.9
6.7
39
139
H53.1
ICD-10 Finland
Subjective visual disturbances
2.0
6.7
76
381
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
2.9
6.6
38
132
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
6.6
624
5208
N06AX16
ATC
venlafaxine; oral
1.6
6.6
159
1018
R03BB04
ATC
tiotropium bromide; inhalant
2.0
6.6
84
437
R52.1
ICD-10 Finland
Chronic intractable pain
7.8
6.6
14
18
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
3.1
6.6
33
107
D06
ICPC
Abdominal pain localized other
1.9
6.6
94
513
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.6
6.6
46
181
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.7
6.5
129
780
S18
ICPC
Laceration/cut
1.3
6.5
505
4089
E26.0
ICD-10 Finland
Primary hyperaldosteronism
6.9
6.5
15
22
J01DA01
ATC
[U] cefalexin; systemic
1.3
6.5
830
7231
Z08
ICPC
Social welfare problem
5.3
6.5
18
34
L15
ICPC
Knee symptom/complaint
1.5
6.5
254
1823
N30.9
ICD-10 Finland
Cystitis, unspecified
2.2
6.5
65
307
C08CA05
ATC
nifedipine; systemic
2.2
6.4
65
308
X58
ICD-10 Finland
Exposure to other specified factors
1.6
6.4
163
1059
L14
ICPC
Leg/thigh symptom/complaint
1.9
6.4
87
468
N05AX12
ATC
aripiprazole; systemic
2.4
6.4
49
205
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.8
6.4
105
601
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.5
6.3
211
1464
E0000UV
ATC
NA
1.3
6.3
498
4040
I47.9
ICD-10 Finland
Paroxysmal tachycardia, unspecified
4.0
6.3
23
58
I15.8
ICD-10 Finland
Other secondary hypertension
9.3
6.3
12
13
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
3.3
6.3
29
89
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.9
6.2
36
127
A02BC04
ATC
rabeprazole; oral
1.8
6.2
95
532
M48.0
ICD-10 Finland
Spinal stenosis
1.7
6.2
126
769
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.1
6.2
68
336
P03
ICPC
Feeling depressed
1.8
6.1
103
594
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.8
6.1
94
527
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
6.1
333
2543
M54.2
ICD-10 Finland
Cervicalgia
1.9
6.1
84
452
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.0
6.1
32
108
SPAT1254
SPAT
Administration of medicine
1.6
6.0
156
1018
W19
ICD-10 Finland
Unspecified fall
1.7
6.0
111
660
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.1
6.0
63
307
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
6.0
945
8429
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
137
144
10.21
118.23
1.2
1.4
nmol/l
0.3
0.5
—
8
12
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
137
145
10.14
117.63
1.2
1.4
nmol/l
9.0
0.7
0.48
130
137
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
525
1953
3.38
109.89
4.0
2.7
ng/l
121.6
561.2
4.41
408
1437
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
126
133
10.11
108.29
1.1
1.4
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
125
139
9.59
103.31
1.7
1.3
mu/l
38.5
40.5
0.08
112
118
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
118
134
9.35
95.91
1.7
1.3
pmol/l
318.7
268.5
0.83
96
100
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
114
131
9.22
91.77
1.2
1.3
nmol/l
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
782
4157
2.55
79.61
3.8
2.6
ng/l
22.9
45.3
3.75
519
2680
(3013826) Glucose [Moles/volume] in Serum or Plasma
1168
7639
2.49
73.39
5.0
4.0
mmol/l
6.5
6.6
1.89
1121
7039
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1011
6480
2.27
62.40
6.6
6.1
mmol/l
1.2
1.2
0.65
853
5488
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
934
5881
2.22
59.11
6.2
5.5
mmol/l
1.2
1.2
0.81
853
5297
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
489
2363
2.47
57.81
1.8
1.6
mg/l
0.8
1.3
3.71
371
1812
(3032080) INR in Blood by Coagulation assay
799
4815
2.18
55.43
8.8
7.2
inr
1.2
1.2
0.30
262
1355
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1004
6743
2.10
51.01
5.6
5.9
umol/l
10.9
11.9
1.39
947
6388
(3037467) Urinalysis macro (dipstick) panel - Urine
1279
9479
2.19
49.28
5.0
3.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1384
10608
2.30
48.71
7.8
6.8
u/l
78.1
79.0
0.32
1307
9916
(3018418) pH of Serum or Plasma
642
3747
2.11
46.43
4.4
3.8
ph
7.4
7.4
0.13
125
670
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
653
3846
2.09
46.00
2.8
2.3
u/l
58.7
57.6
0.15
606
3523
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1407
11022
2.24
44.33
4.6
3.9
pmol/l
14.8
14.7
0.34
1299
10001
(3036481) Cortisol [Moles/volume] in Serum or Plasma
266
1085
2.70
43.72
2.1
2.2
nmol/l
353.4
377.9
1.12
235
996
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1591
13264
2.66
41.44
5.6
4.5
mu/l
1.9
2.1
0.99
1488
12111
(3019550) Sodium [Moles/volume] in Serum or Plasma
1719
14945
4.02
41.43
18.7
12.4
mmol/l
139.6
139.7
0.76
1700
14498
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
618
3683
2.03
41.22
2.6
2.0
u/l
168.7
254.8
1.75
589
3466
(3023103) Potassium [Moles/volume] in Serum or Plasma
1721
14999
4.03
40.77
18.9
12.5
mmol/l
3.9
4.0
0.80
1700
14519
(3024561) Albumin [Mass/volume] in Serum or Plasma
842
5630
1.93
39.78
4.8
4.6
g/l
36.4
35.9
1.91
774
5235
(3013707) Erythrocyte sedimentation rate by Westergren method
1314
10216
2.05
39.36
4.4
3.6
mm/h
11.0
11.8
1.58
1230
9410
(3002582) Erythrocytes [#/volume] in Urine
623
3781
1.99
39.03
4.1
2.9
e6/l
109.6
83.8
0.17
480
2804
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1675
14477
3.12
37.92
16.6
10.9
mg/l
18.7
23.9
10.68
1354
11002
(36304419) Bacteria [Presence] in Urine
570
3412
1.98
36.73
3.9
2.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
576
3462
1.97
36.66
3.9
2.8
e6/l
0.2
0.5
4.32
445
2532
(3018095) Leukocytes [#/volume] in Urine
709
4578
1.90
36.35
4.6
3.4
e6/l
93.9
96.1
0.03
511
3053
(3031040) Bacteria [#/volume] in Urine by Automated count
1188
9042
1.91
36.25
5.7
4.0
e6/l
469.9
2705.8
1.70
15
126
(3000850) Epithelial cells [#/volume] in Urine
459
2560
2.06
35.96
3.2
2.3
e6/l
5.5
6.9
1.32
403
2207
(3018677) aPTT in Platelet poor plasma by Coagulation assay
352
1775
2.22
35.79
2.2
2.0
s
28.8
29.7
2.01
343
1722
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
502
2897
2.01
35.75
2.7
2.6
ng/l
821.2
1238.8
2.59
420
2435
(3044889) 12 lead EKG panel
1246
9670
1.93
35.37
4.0
3.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
687
4466
1.87
33.90
5.7
5.7
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
26
14
18.83
32.64
1.2
1.3
umol/24h
0.7
0.6
—
12
6
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
660
4319
1.83
31.29
3.5
3.1
u/l
30.3
33.1
1.12
618
4094
(3026782) Osmolality of Urine
426
2455
1.96
29.70
3.1
2.4
mosm/kgh2o
532.6
553.6
1.17
368
2056
(3013650) Neutrophils [#/volume] in Blood by Automated count
1039
7855
1.76
29.41
9.8
8.8
e9/l
4.1
3.9
1.50
921
6777
(3006315) Basophils [#/volume] in Blood
917
6694
1.75
29.36
6.4
5.6
e9/l
0.0
0.0
0.73
810
5703
(3001604) Monocytes [#/volume] in Blood
913
6679
1.74
28.81
6.5
5.5
e9/l
0.6
0.6
1.69
811
5684
(3009261) Glucose [Presence] in Urine by Test strip
925
6793
1.74
28.78
4.3
3.4
estimate
0.0
0.0
0.80
204
1219
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1535
13130
2.12
28.76
5.6
5.1
mmol/mol
38.5
39.1
2.38
1418
12138
(3006504) Eosinophils/100 leukocytes in Blood
870
6290
1.74
28.54
6.5
5.8
%
2.8
2.8
0.04
813
5839
(3019069) Monocytes/100 leukocytes in Blood
874
6334
1.73
28.37
6.8
6.0
%
8.7
8.5
0.73
823
5921
(3021601) Nitrite [Presence] in Urine by Test strip
915
6723
1.73
28.20
5.7
4.6
estimate
0.0
0.0
0.00
208
1252
(3013115) Eosinophils [#/volume] in Blood
937
6933
1.73
28.13
6.6
5.8
e9/l
0.2
0.2
0.28
842
5984
(3019198) Lymphocytes [#/volume] in Blood
932
6890
1.73
28.04
6.4
5.6
e9/l
1.9
2.0
0.51
845
5998
(3035350) Ketones [Presence] in Urine by Test strip
908
6668
1.73
27.95
4.3
3.3
estimate
0.0
0.0
0.50
205
1238
(3018010) Neutrophils/100 leukocytes in Blood
883
6443
1.72
27.75
6.3
5.7
%
56.2
56.6
0.43
827
6011
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1605
14022
2.28
27.62
4.8
4.1
mmol/l
5.9
5.8
0.06
1463
12760
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
578
3749
1.80
27.45
1.7
1.6
mmol/l
1.5
1.3
1.22
478
3219
(3002030) Lymphocytes/100 leukocytes in Blood
893
6551
1.72
27.40
6.6
5.8
%
29.0
28.8
0.20
843
6096
(3022096) Basophils/100 leukocytes in Blood
843
6100
1.72
27.10
6.5
5.8
%
0.7
0.7
0.54
788
5671
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
182
775
2.50
26.90
2.7
2.3
ng/l
194.4
162.6
0.42
152
685
(3009508) Creatinine [Moles/volume] in Urine
609
4049
1.76
26.35
3.0
3.2
mmol/l
7.7
7.4
1.02
522
3436
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
274
1421
2.09
25.29
2.9
2.6
umol/l
5.2
8.2
4.67
232
1238
(3012095) Magnesium [Moles/volume] in Serum or Plasma
343
1938
1.95
24.88
3.6
3.3
mmol/l
0.8
0.8
0.47
312
1809
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1647
14744
2.31
23.35
5.2
4.4
mmol/l
2.9
2.8
0.17
1524
13575
(40761511) CBC panel - Blood by Automated count
1697
15408
2.64
23.01
15.6
10.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1617
14399
2.16
22.76
4.7
4.0
mmol/l
1.5
1.5
4.40
1500
13269
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1624
14492
2.18
22.62
4.7
4.0
mmol/l
4.8
4.8
0.43
1513
13415
(3012516) Albumin [Mass/volume] in Urine
552
3716
1.70
22.05
2.9
3.2
mg/l
402.1
339.0
0.11
343
2247
(3033658) Prothrombin time (PT) actual/Normal
508
3345
1.72
22.00
4.3
3.4
%
95.6
93.1
1.66
492
3280
(3020682) Albumin/Creatinine [Ratio] in Urine
575
3920
1.68
21.87
3.4
3.9
mg/mmol
8.4
7.3
0.36
344
2382
(3026008) Bacteria identified in Urine by Culture
582
3987
1.68
21.69
3.7
2.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
639
4507
1.65
21.15
3.4
3.5
mmol/l
2.4
2.4
0.60
554
3931
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
785
5828
1.61
21.08
2.6
2.2
nmol/l
76.7
77.5
0.36
706
5227
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
349
2083
1.84
21.06
3.5
2.6
e6/l
0.8
1.2
2.33
204
1136
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1543
13639
1.89
20.31
15.6
10.5
ml/min/173m2
83.6
82.9
0.63
1319
10928
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
221
1146
2.06
20.19
3.1
2.1
u/l
35.7
83.9
0.61
178
984
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
720
5275
1.61
20.17
2.1
1.9
pmol/l
95.4
96.6
0.26
354
2643
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
309
1798
1.87
20.15
1.8
1.7
—
—
—
0
0
(3012544) pH of Venous blood
206
1042
2.10
20.11
4.9
3.7
—
7.4
—
0
5
(3001122) Ferritin [Mass/volume] in Serum or Plasma
784
5875
1.59
19.89
3.2
2.6
ug/l
115.1
119.0
0.18
718
5444
(3013512) EKG study
529
3603
1.66
19.82
3.9
3.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1428
12372
1.73
19.65
21.0
13.9
%
13.5
13.6
2.11
1413
12061
(3012501) Base excess in Blood by calculation
72
221
3.35
19.39
2.3
3.7
mmol/l
2.2
2.9
1.43
48
147
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
469
3111
1.69
19.38
1.3
1.3
u/ml
1.1
1.8
1.31
112
778
(40768797) Stomach Pathology biopsy report
292
1689
1.87
19.35
1.2
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
283
1624
1.88
19.21
6.6
5.5
mmol/l
1.1
1.1
0.50
268
1508
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1707
15720
2.52
19.20
11.9
9.1
u/l
26.7
25.9
0.97
1661
15116
(3014576) Chloride [Moles/volume] in Serum or Plasma
252
1395
1.94
19.08
6.4
6.5
mmol/l
104.6
104.6
0.07
246
1365
(3002032) Base excess in Venous blood by calculation
198
1007
2.08
19.02
5.0
3.8
mmol/l
1.9
1.7
0.26
169
788
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
326
1966
1.80
18.84
3.6
2.7
e6/l
4.2
3.0
0.73
179
1031
(3023368) Bacteria identified in Blood by Culture
476
3200
1.66
18.57
4.4
3.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
411
2683
1.69
17.84
1.7
1.4
g/l
2.2
2.3
0.44
231
1600
(3020779) Urea [Moles/volume] in Serum or Plasma
195
1015
2.03
17.55
7.7
7.1
mmol/l
8.3
8.9
0.62
185
965
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1542
13798
1.80
17.18
4.1
3.6
mmol/l
1.4
1.3
5.05
1424
12637
(3021589) Normoblasts [#/volume] in Blood
805
6230
1.53
16.75
10.2
8.4
e9/l
0.0
0.0
0.31
686
5048
(3005322) IgE [Units/volume] in Serum or Plasma
143
675
2.21
16.58
1.4
1.2
u/ml
660.9
230.2
0.70
123
623
(3000991) Gas panel - Venous blood
186
973
2.02
16.49
7.7
7.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
344
2183
1.71
16.45
1.8
1.7
nmol/l
1126.0
1149.2
0.19
251
1631
(3026493) Urate [Moles/volume] in Serum or Plasma
473
3268
1.61
16.19
2.8
2.4
umol/l
5206.7
6227.0
0.19
428
2889
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1134
9490
1.52
15.94
3.6
2.9
u/l
52.2
46.1
1.02
1064
8874
(3004789) Transferrin [Mass/volume] in Serum or Plasma
278
1675
1.78
15.93
2.8
2.3
g/l
2.4
2.4
1.12
257
1544
(3003396) Base excess in Arterial blood by calculation
218
1219
1.90
15.89
6.4
7.1
mmol/l
0.8
1.0
0.25
181
961
(3010421) pH of Blood
75
267
2.89
15.75
2.3
3.6
ph
7.4
7.4
1.47
69
218
(3022948) Iron [Moles/volume] in Serum or Plasma
297
1837
1.74
15.51
2.7
2.3
umol/l
14.4
13.7
0.86
277
1694
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
386
2573
1.64
15.17
1.7
1.5
—
—
—
0
0
(3024731) MCV [Entitic volume]
1761
16681
3.10
14.72
25.1
16.5
fl
90.6
90.7
0.46
1749
16415
(3007461) Platelets [#/volume] in Blood
1760
16668
3.06
14.69
25.2
16.5
e9/l
257.3
255.3
0.65
1730
16166
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
29
55
5.34
14.68
1.2
1.6
nmol/l
1.6
7.9
0.82
24
43
(3035941) MCH [Entitic mass]
1761
16683
3.09
14.68
25.1
16.4
pg
30.2
30.2
0.16
1749
16415
(3026361) Erythrocytes [#/volume] in Blood
1761
16684
3.09
14.66
25.3
16.5
e12/l
4.5
4.5
2.28
1729
16140
(3010813) Leukocytes [#/volume] in Blood
1761
16690
3.08
14.53
25.3
16.5
e9/l
6.7
6.6
1.32
1727
16139
(3011397) Hemoglobin [Presence] in Urine by Test strip
443
3081
1.58
14.52
3.9
3.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1761
16691
3.08
14.51
25.4
16.6
g/l
136.3
135.3
2.20
1749
16427
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
213
1224
1.84
14.20
6.4
7.0
kpa
5.0
5.1
1.43
202
1169
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
673
5144
1.49
14.17
4.7
3.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
283
1770
1.71
14.11
1.3
1.3
titre
477.8
603.5
0.58
54
388
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
211
1213
1.84
14.05
1.8
1.6
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
188
1042
1.90
14.04
6.8
7.7
g/l
121.6
120.8
0.23
179
994
(3021960) Folate [Moles/volume] in Serum or Plasma
424
2942
1.58
13.96
1.5
1.5
nmol/l
21.1
21.0
0.02
361
2485
(3027801) Oxygen [Partial pressure] in Arterial blood
212
1224
1.83
13.92
6.4
7.0
kpa
12.9
13.3
0.49
202
1169
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
210
1212
1.83
13.80
1.8
1.6
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
194
1093
1.87
13.76
6.6
7.6
%
96.0
96.1
0.09
183
1050
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
253
1548
1.74
13.63
3.0
2.4
%
23.4
23.5
0.05
218
1332
(3048689) Calprotectin [Mass/mass] in Stool
262
1633
1.71
13.18
2.3
2.4
ug/g
79.4
135.5
4.31
207
1284
(3014111) Lactate [Moles/volume] in Serum or Plasma
177
983
1.89
13.12
5.2
6.9
mmol/l
1.3
1.3
0.01
170
949
(3005719) IgG [Mass/volume] in Serum or Plasma
169
927
1.91
13.01
3.5
2.6
g/l
9.8
10.5
1.61
155
845
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
438
3107
1.54
12.95
2.4
2.1
mg/l
2.8
2.9
0.45
366
2628
(40758558) Short blood count panel - Blood
476
3441
1.52
12.88
6.9
6.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1114
9491
1.45
12.82
3.6
2.9
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
103
476
2.23
12.59
1.6
1.9
u/l
40.4
40.2
0.04
90
426
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
175
982
1.87
12.55
4.3
3.8
ng/l
82.6
80.4
0.12
153
844
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
127
640
2.06
12.45
1.5
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
59
210
2.87
12.44
2.6
3.3
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
82
345
2.44
12.42
1.3
1.4
mg/l
562.9
539.1
0.11
74
327
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
100
462
2.23
12.24
2.7
2.9
%
0.7
0.6
0.44
94
442
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
122
610
2.07
12.22
7.0
9.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
75
305
2.52
12.22
1.3
1.5
e6/l
15.1
41.2
0.62
57
237
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
75
305
2.52
12.22
1.3
1.4
mmol/l
3.9
3.7
0.99
68
287
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
75
305
2.52
12.22
1.3
1.6
e6/l
964.8
1531.6
0.23
60
246
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
84
362
2.38
12.08
1.9
1.6
g/l
0.2
0.2
0.62
77
343
(3022217) INR in Platelet poor plasma by Coagulation assay
219
1330
1.74
12.06
19.0
19.4
inr
1.2
1.2
0.42
24
192
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
118
586
2.08
12.03
6.2
4.4
mmol/l
24.4
23.9
0.79
108
536
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
176
1006
1.83
11.90
3.1
3.6
mmol/l
1.2
1.2
0.48
151
859
(3044290) Cell count panel - Cerebral spinal fluid
72
291
2.54
11.89
1.2
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
46
146
3.21
11.82
1.4
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
484
3581
1.48
11.50
5.1
3.6
estimate
0.0
0.0
0.88
202
1213
(40761536) Microorganisms panel - Urine sediment
194
1155
1.76
11.44
5.2
3.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
140
754
1.93
11.38
5.4
3.8
kpa
5.2
5.1
0.63
130
701
(3041096) Erythrocytes [Presence] in Urine by Automated
494
3679
1.47
11.33
4.3
3.1
—
—
—
0
0
(3009343) pH of Capillary blood
138
743
1.93
11.23
5.5
3.8
ph
7.4
7.4
0.16
16
77
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
142
774
1.91
11.14
2.6
1.9
ug/l
4.2
7.4
3.49
122
667
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
84
376
2.29
11.10
2.0
1.6
g/l
1.2
1.2
0.25
78
357
(3049717) Cytology report of Urine Cyto stain
88
406
2.23
10.83
2.5
2.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
53
195
2.77
10.56
1.8
2.3
%
17.4
16.4
0.81
22
99
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
132
716
1.91
10.51
5.6
3.8
mmol/l
1.6
1.6
0.07
103
529
(3028026) IgM [Mass/volume] in Serum or Plasma
133
725
1.90
10.43
2.2
1.8
g/l
1.1
1.4
2.49
118
654
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
160
925
1.80
10.42
2.6
2.4
au/ml
25.3
23.8
—
8
64
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
338
2367
1.53
10.36
1.3
1.2
iu/ml
37.5
37.0
0.01
94
761
(3047181) Lactate [Moles/volume] in Blood
76
337
2.31
10.28
5.5
5.5
mmol/l
1.2
1.3
0.25
67
283
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
143
806
1.84
10.11
3.3
3.3
pmol/l
4.4
4.5
0.51
125
720
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
79
359
2.26
10.10
6.9
5.5
mg/l
1.2
1.4
1.92
73
331
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
147
837
1.82
10.06
1.4
1.3
au/ml
52.7
48.4
—
10
45
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
144
817
1.83
9.97
1.4
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1495
13729
1.51
9.89
18.9
12.3
%
40.0
39.8
0.58
1083
10257
(3008152) Bicarbonate [Moles/volume] in Arterial blood
120
648
1.91
9.70
7.9
6.6
mmol/l
25.2
24.6
0.88
109
597
(3007853) Bacteria identified in Skin by Aerobe culture
220
1419
1.63
9.59
1.9
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
318
2232
1.52
9.59
1.3
1.2
u/ml
7.5
13.3
1.24
110
891
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
797
6602
1.37
9.58
4.2
3.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
224
1453
1.62
9.54
1.3
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
207
1317
1.65
9.53
4.0
4.4
u/l
231.5
252.7
1.26
197
1249
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
56
225
2.54
9.42
1.5
1.6
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
88
435
2.08
9.13
4.9
4.5
%
0.9
0.9
0.11
78
397
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
89
444
2.06
9.02
4.8
4.4
%
1.6
1.6
0.20
79
402
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
55
226
2.48
8.84
1.6
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
140
818
1.77
8.80
1.2
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
52
209
2.53
8.76
3.0
3.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
327
2356
1.47
8.61
2.7
3.1
mmol/l
2.4
2.5
1.02
281
2093
(3025941) Bacteria identified in Stool by Culture
128
734
1.80
8.58
1.3
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
155
942
1.71
8.49
2.7
2.5
g/l
66.9
66.7
0.16
141
857
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
12
6
20.12
8.47
1.2
1.2
umol/24h
1.5
1.4
—
12
6
(3019150) Specific gravity of Urine by Refractometry
382
2848
1.43
8.38
4.4
3.7
kg/l
1.0
1.0
0.41
53
420
(3027945) Reticulocytes/100 erythrocytes in Blood
201
1319
1.59
8.14
3.4
2.9
%
1.6
1.7
0.43
178
1164
(3019060) Gas panel - Arterial blood
115
651
1.82
8.05
5.6
4.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
75
367
2.09
8.03
3.1
2.8
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
58
256
2.31
8.00
9.9
2.9
mmol/l
25.1
25.0
0.05
53
217
(4094501)
62
282
2.24
7.97
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
226
1535
1.54
7.87
1.7
1.7
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
46
184
2.54
7.85
1.4
1.2
u/l
21.0
47.8
0.93
41
152
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
54
235
2.34
7.70
3.3
3.3
%
54.6
56.7
0.46
54
235
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
43
169
2.58
7.62
1.7
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
348
2592
1.42
7.61
2.0
1.8
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
48
200
2.44
7.54
1.7
1.4
mmol/l
65.6
62.0
0.21
33
161
(3030905) Polymorphonuclear cells [#/volume] in Blood
52
226
2.34
7.45
3.1
3.0
e9/l
3.4
4.0
1.53
52
226
(3004588) Protein electrophoresis panel - Serum or Plasma
130
783
1.71
7.37
2.5
2.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
381
2903
1.40
7.28
5.6
4.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
105
597
1.81
7.27
2.4
2.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
234
1635
1.50
7.12
2.1
1.8
%
1.4
1.4
0.59
213
1453
(1002224) Polysomnography panel
94
520
1.85
7.11
1.1
1.0
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
83
441
1.92
7.10
4.0
3.1
%
48.8
49.9
0.16
83
432
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
30
101
3.00
7.09
1.2
1.7
—
—
—
0
0
(3039000) Anion gap in Blood
55
252
2.22
6.98
5.9
6.2
mmol/l
10.7
11.2
0.55
47
218
(3018572) Chloride [Moles/volume] in Blood
55
252
2.22
6.98
5.9
6.2
mmol/l
105.7
105.0
0.49
47
218
(36660697) Celiac disease serology panel - Serum
170
1115
1.58
6.90
1.2
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
542
4398
1.33
6.88
2.6
2.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
85
461
1.89
6.85
1.5
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
38
149
2.58
6.79
1.1
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
211
1459
1.51
6.74
1.5
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
86
473
1.86
6.64
1.7
1.6
mu/l
269.5
297.2
0.54
78
423
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
151
975
1.60
6.56
1.2
1.2
iu/ml
89.4
149.0
1.04
46
356
(3024980) IgG subclass 4 [Mass/volume] in Serum
43
184
2.37
6.42
1.4
1.7
g/l
0.5
0.9
3.70
35
142
(3000492) Spirometry study
169
1126
1.55
6.41
1.4
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
26
86
3.05
6.35
3.3
1.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
223
1584
1.47
6.23
1.7
1.6
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
114
695
1.68
6.22
7.7
9.1
%
0.7
0.7
0.28
114
695
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
422
3344
1.34
6.20
2.3
2.1
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
28
99
2.86
6.11
1.5
1.4
g/l
0.3
0.4
2.14
21
68
(3027135) IgG subclass 1 [Mass/volume] in Serum
28
99
2.86
6.11
1.5
1.4
g/l
5.4
6.8
1.44
21
67
(3028192) IgG subclass 2 [Mass/volume] in Serum
28
99
2.86
6.11
1.5
1.4
g/l
2.5
3.1
1.04
21
67
(4062490)
28
100
2.83
6.00
1.5
1.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
61
310
2.00
5.98
8.8
4.2
kpa
8.8
8.9
0.12
56
286
(44790048)
29
106
2.76
5.96
1.2
1.3
—
—
—
0
0
(44790047)
29
106
2.76
5.96
1.2
1.3
—
—
—
0
0
(44806118)
29
106
2.76
5.96
1.2
1.3
—
—
—
0
0
(44790049)
29
106
2.76
5.96
1.2
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
46
212
2.20
5.81
2.4
2.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
84
481
1.78
5.74
3.2
4.3
g/l
0.1
0.3
3.43
35
219
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
58
296
1.99
5.63
1.2
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
190
1335
1.47
5.62
3.9
2.8
—
—
—
0
0
(4198724)
18
51
3.55
5.61
2.7
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
146
973
1.54
5.55
2.4
2.8
e9/l
65.4
67.3
0.28
98
700
(3017181) Myelocytes/100 leukocytes in Blood
156
1057
1.52
5.50
4.4
4.2
%
1.1
0.9
0.31
42
297
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
34
141
2.44
5.47
1.1
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
154
2.36
5.42
1.2
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
146
979
1.53
5.41
3.0
2.4
ml/min/173m2
71.2
68.7
0.28
54
374
(3036489) Thrombin time
80
462
1.77
5.33
2.0
2.0
s
22.8
21.0
0.70
67
414
(1001926) Buprenorphine [Presence] in Urine by Screen method
74
418
1.80
5.31
2.1
2.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
32
132
2.45
5.22
1.1
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
39
176
2.24
5.21
8.8
2.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
58
305
1.93
5.20
1.5
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
345
2720
1.33
5.17
1.7
1.6
pmol/l
20788965.8
25734762.0
0.08
279
2281
(3015171) Extractable nuclear Ab [Units/volume] in Serum
80
470
1.73
5.04
1.3
1.3
u/ml
0.5
1.5
—
7
49
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
180
1279
1.45
5.03
2.3
2.3
g/l
0.2
0.2
0.57
163
1215
(3025159) Blasts/100 leukocytes in Blood
142
962
1.52
5.03
4.5
4.3
%
0.2
0.5
0.31
32
237
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
67
374
1.82
5.01
2.5
2.5
g/l
3.6
3.6
0.09
61
350
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
82
2.83
4.98
1.3
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
149
1022
1.50
4.98
4.3
4.2
%
0.1
0.1
0.79
39
279
(3017817) Protein [Mass] in Urine collected for unspecified duration
27
105
2.60
4.98
3.1
2.4
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
27
106
2.57
4.89
1.2
1.2
mmol/l
1.9
2.1
0.70
22
99
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
73
422
1.76
4.87
2.3
2.0
ug/l
1.2
1.2
0.03
60
371
(3003338) MCHC [Mass/volume]
1368
12795
1.28
4.87
22.4
14.2
g/l
333.1
332.5
1.57
1362
12698
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
26
101
2.60
4.81
1.2
1.1
mg/l
233.8
297.9
1.31
21
84
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
85
515
1.68
4.81
4.4
4.2
mmol/l
24.7
24.8
0.04
76
482
(40768804) Tissue Pathology biopsy report
667
5765
1.25
4.79
2.1
2.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
46
230
2.03
4.77
2.3
2.1
g/l
136.5
128.6
1.76
36
167
(3042733) HLA Ab [Presence] in Serum
13
33
3.96
4.71
6.7
4.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
91
565
1.64
4.69
5.8
4.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
34
152
2.26
4.67
1.3
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
31
134
2.34
4.60
1.3
1.5
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
66
379
1.77
4.53
1.1
1.1
u/ml
5.3
6.6
—
6
45
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
33
149
2.24
4.45
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
69
404
1.74
4.44
5.6
4.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
58
323
1.82
4.41
1.9
1.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
23
88
2.63
4.40
2.9
5.7
%
10.5
11.5
0.71
23
88
(3011288) Drugs identified in Urine by Screen method
64
368
1.77
4.38
2.5
2.9
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
60
339
1.80
4.36
3.9
3.3
mg/l
44.5
63.0
0.47
50
288
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
21
77
2.75
4.35
1.2
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
132
910
1.49
4.33
2.0
1.9
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
101
657
1.57
4.33
1.4
1.4
iu/l
26.7
30.2
0.47
89
561
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
216
1629
1.37
4.31
2.0
2.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
75
454
1.68
4.29
1.5
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
192
1422
1.39
4.28
1.7
1.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
139
971
1.47
4.27
4.4
4.0
%
0.7
0.6
0.22
32
218
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
108
716
1.54
4.26
1.1
1.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
411
1.71
4.19
2.3
2.4
g/l
9.9
10.3
0.34
58
353
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
59
338
1.77
4.11
3.9
3.3
mg/l
33.9
47.8
0.40
48
286
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
61
353
1.75
4.11
2.3
2.4
%
184.8
183.3
0.04
53
342
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
276
2178
1.32
4.07
1.7
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
27
117
2.33
4.02
2.1
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
62
363
1.73
4.02
1.5
1.4
u/l
9.2
10.5
0.35
54
291
(3038177) Helicobacter pylori Ab [Presence] in Serum
39
197
2.00
3.99
1.2
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
120
828
1.48
3.94
2.8
2.1
nmol/l
11.7
13.1
0.93
102
743
(3042936) Bacteria identified in Isolate by Culture
220
1689
1.34
3.92
1.9
1.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
81
513
1.61
3.91
1.8
2.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
194
1462
1.37
3.90
2.0
1.9
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
79
499
1.61
3.86
2.5
1.8
g/l
1.4
1.6
0.66
66
426
(3006653) Thiamine [Moles/volume] in Blood
18
65
2.79
3.85
1.4
1.1
nmol/l
124.9
135.1
0.48
18
65
(3027008) Opiates [Presence] in Urine
87
563
1.57
3.84
1.9
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
87
564
1.57
3.82
1.9
1.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
30
140
2.16
3.78
1.3
1.4
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
6
5
12.03
3.76
1.0
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
92
607
1.54
3.74
2.1
1.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
68
417
1.66
3.74
1.6
1.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
25
109
2.31
3.69
3.0
2.6
e9/l
1.7
1.2
0.82
16
60
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
55
320
1.74
3.67
1.4
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
26
116
2.26
3.65
1.3
1.4
—
—
—
0
0
(3019225) pH of Specimen
178
1338
1.37
3.65
3.5
3.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
85
556
1.55
3.60
2.0
1.9
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
43
234
1.86
3.57
4.8
3.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
53
309
1.74
3.52
2.7
2.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
58
347
1.69
3.52
1.4
1.4
ug/g
291.4
282.9
0.12
30
199
(3030313) Adrenal Ab [Titer] in Serum
6
6
10.03
3.50
1.0
1.7
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
6
6
10.03
3.50
1.3
1.5
—
—
—
0
0
(4010399)
109
758
1.47
3.47
1.3
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
23
100
2.32
3.43
1.1
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
41
223
1.86
3.42
2.2
3.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
70
444
1.60
3.40
1.3
1.3
miu/ml
238.7
227.9
0.08
30
207
(3027944) Amphetamines [Presence] in Urine
84
556
1.54
3.40
1.9
1.8
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
375
3145
1.24
3.37
5.0
4.6
ug/l
2.0
2.5
1.86
332
2821
(3003694) ABO and Rh group [Type] in Blood
487
4198
1.22
3.37
1.5
1.5
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
46
263
1.77
3.29
1.4
1.2
u/ml
47.4
38.7
—
5
38
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
58
355
1.65
3.25
2.2
2.4
g/l
37.8
38.0
0.11
51
308
(40768446) Kidney Pathology biopsy report
15
54
2.79
3.25
2.2
1.7
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
12
38
3.17
3.21
1.2
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
11
33
3.35
3.19
2.4
2.4
ug/l
15.8
269.6
0.50
11
28
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
49
2.87
3.19
1.1
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
11
6.38
3.18
11.7
7.9
mmol/l
5.1
6.6
—
7
11
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
21
91
2.32
3.17
2.7
2.0
%
11.1
14.7
0.52
13
38
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
47
274
1.73
3.16
1.8
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
13
44
2.97
3.13
4.5
13.6
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
45
260
1.75
3.12
1.7
1.5
u/ml
67.9
109.9
—
10
44
(40761535) Cells panel - Urine sediment
135
997
1.38
3.11
3.3
3.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
62
391
1.61
3.11
2.5
2.6
g/l
0.4
1.0
1.69
52
343
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
34
180
1.91
3.10
1.1
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
12
39
3.09
3.09
1.2
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
14
50
2.81
3.09
1.0
1.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
448
1.56
3.07
2.3
2.4
g/l
3.9
3.8
0.15
52
316
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
448
1.56
3.07
2.3
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
448
1.56
3.07
2.3
2.4
g/l
7.4
7.5
0.11
55
336
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
35
189
1.87
3.02
1.4
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
33
175
1.90
3.01
2.4
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
419
1.57
2.99
2.4
2.4
g/l
3.0
3.2
0.78
54
329
(3022475) Manganese [Moles/volume] in Blood
5
5
10.02
2.98
1.0
1.6
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
33
176
1.89
2.96
2.1
2.5
umol/l
6.7
6.6
0.01
21
128
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
35
3.16
2.93
1.0
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
23
108
2.14
2.91
1.9
1.3
promille
1.1
1.2
0.05
18
90
(3014148) Varicella zoster virus Ab [Titer] in Serum
31
163
1.92
2.90
1.1
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
22
4.11
2.88
17.1
7.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
100
712
1.43
2.86
1.7
1.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
27
136
2.00
2.86
1.3
1.5
mosm/kgh2o
274.9
279.4
0.50
20
106
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
13
47
2.78
2.81
1.0
1.2
%
112.2
110.0
0.18
13
41
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
62
404
1.55
2.74
2.1
2.3
%
92.6
91.4
0.19
56
378
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
33
181
1.84
2.74
1.3
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
21
98
2.16
2.71
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
14
54
2.61
2.70
1.1
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
54
342
1.60
2.70
1.0
1.3
—
1119.2
—
0
13
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
8
19
4.22
2.68
1.1
1.9
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
18
79
2.29
2.68
2.9
2.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
91
646
1.43
2.67
3.5
3.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
42
250
1.70
2.66
1.5
1.3
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
56
361
1.57
2.61
1.5
1.2
u/ml
21.4
23.0
—
6
28
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
17
74
2.31
2.58
1.2
1.7
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
51
323
1.60
2.56
1.4
1.3
u/ml
2.2
3.2
—
6
41
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
7
7.16
2.55
1.2
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
119
1565
0.74
2.53
1.3
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
61
404
1.53
2.53
1.1
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
22
108
2.05
2.52
2.4
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
22
108
2.05
2.52
1.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
61
405
1.52
2.51
1.1
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
72
496
1.47
2.49
1.1
1.1
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
16
69
2.33
2.48
2.3
1.4
umol/l
36.9
23.0
0.69
16
63
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
100
734
1.38
2.45
1.9
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
589
5293
1.17
2.44
2.9
2.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
46
288
1.61
2.44
1.7
1.4
—
10.2
—
0
7
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
51
328
1.57
2.42
1.4
1.3
u/ml
3.0
8.7
—
7
68
(42529406) Shigella sp [Presence] in Stool by Culture
61
409
1.51
2.41
1.1
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
34
197
1.74
2.40
1.4
1.1
u/ml
7.4
3.0
0.48
13
62
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
34
197
1.74
2.40
1.4
1.2
u/ml
6.2
3.2
0.77
11
80
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
19
90
2.12
2.39
1.2
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
46
290
1.60
2.38
1.7
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
41
251
1.65
2.38
1.4
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
58
386
1.52
2.37
1.5
1.6
iu/ml
37.5
0.2
0.50
12
68
(4034850)
64
435
1.49
2.37
9.6
7.0
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
20
97
2.07
2.37
1.1
1.0
ng/l
29.0
44.7
—
10
61
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
20
97
2.07
2.37
1.1
1.0
ng/l
731.1
702.9
0.06
12
60
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
20
97
2.07
2.37
1.3
1.6
%
52.4
31.6
—
10
69
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
25
132
1.91
2.36
1.8
1.6
%
54.8
64.2
0.50
12
91
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
22
111
1.99
2.36
1.0
1.2
u/l
65.9
65.0
0.02
13
75
(3033705) Calcium.ionized [Moles/volume] in Venous blood
23
118
1.96
2.35
2.2
2.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
51
331
1.56
2.34
2.8
2.9
u/ml
0.3
0.4
1.67
30
176
(3021879) Hepatitis B virus core Ab [Presence] in Serum
132
1021
1.32
2.31
1.4
1.5
—
—
—
0
0
(4027681)
18
85
2.13
2.29
1.3
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
42
262
1.62
2.27
1.3
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
16
72
2.23
2.27
3.3
3.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
44
278
1.60
2.27
1.4
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
53
350
1.53
2.26
1.6
1.9
iu/l
4.8
4.9
0.02
18
114
(3022621) pH of Urine by Test strip
118
902
1.33
2.25
3.3
3.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
18
3.90
2.25
2.4
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
18
86
2.10
2.23
1.2
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
14
60
2.34
2.22
1.6
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
36
2.79
2.20
1.0
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
36
2.79
2.20
3.3
2.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
24
3.34
2.18
1.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
221
1837
1.23
2.17
1.3
1.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
27
151
1.80
2.16
1.7
1.5
—
32.1
—
0
7
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
109
1413
0.76
2.13
1.6
1.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
43
275
1.58
2.12
1.7
1.2
u/ml
320.2
237.6
0.71
25
165
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
26
145
1.80
2.11
2.0
1.6
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
5
10
5.01
2.07
1.2
1.3
u/l
9.2
16.3
—
5
10
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
21
110
1.92
2.06
1.2
1.4
mmol/l
10.1
12.8
—
7
27
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
6
15
4.01
2.04
1.2
1.9
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
37
231
1.61
2.03
1.2
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
37
231
1.61
2.03
1.2
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
11
44
2.51
2.01
1.0
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
14
63
2.23
2.01
4.0
2.8
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
19
97
1.97
2.00
1.1
1.0
ng/l
234.8
298.0
0.66
11
63
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
9
32
2.82
2.00
1.8
1.8
ug/l
0.4
0.4
—
9
18
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
41
264
1.57
1.98
1.4
1.3
u/ml
3.9
2.7
—
6
20
(3032773) Endomysium IgG Ab [Titer] in Serum
21
112
1.89
1.96
1.2
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
33
522
0.63
1.95
1.5
1.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
27
2.97
1.93
6.3
3.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
27
2.97
1.93
6.3
3.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
10
39
2.57
1.92
1.0
1.1
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
35
219
1.61
1.91
1.9
2.0
—
4.5
—
0
6
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
27
158
1.72
1.89
2.5
2.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
26
151
1.73
1.87
1.3
1.3
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
15
72
2.09
1.86
1.1
1.3
—
72.3
—
0
13
(3045716) Anion gap in Serum or Plasma
11
46
2.40
1.85
1.5
1.6
mmol/l
9.7
9.1
—
6
36
(3024471) HLA-A [Type]
11
46
2.40
1.85
1.0
1.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
47
318
1.49
1.84
1.3
1.6
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
17
3.54
1.84
1.2
2.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
70
945
0.73
1.83
1.4
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
12
53
2.27
1.80
1.1
1.0
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
17
87
1.96
1.80
2.8
2.6
e6/l
514.9
719.7
—
7
35
(3037756) Immunofixation for Serum or Plasma
37
239
1.56
1.79
2.1
1.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
22
124
1.78
1.76
1.1
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
16
81
1.98
1.74
1.0
1.8
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
6
18
3.34
1.74
2.7
1.1
%
69.3
91.2
—
6
18
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
18
3.34
1.74
1.2
1.2
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
18
3.34
1.74
23.5
8.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
68
500
1.37
1.73
2.6
2.2
u/l
3164.7
3756.7
0.13
31
224
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
8
30
2.67
1.72
1.1
1.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
19
103
1.85
1.72
1.8
1.8
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
5
13
3.85
1.71
1.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
13
3.85
1.71
1.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
13
3.85
1.71
1.0
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
11
48
2.30
1.70
2.5
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
11
48
2.30
1.70
2.5
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
11
48
2.30
1.70
2.5
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
11
48
2.30
1.70
2.5
1.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
118
1.79
1.70
1.3
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
16
82
1.96
1.69
2.2
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
16
82
1.96
1.69
2.3
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
16
82
1.96
1.69
2.2
1.6
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
32
204
1.58
1.66
5.6
5.5
umol/l
398.0
374.8
0.34
27
170
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
32
204
1.58
1.66
1.3
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
14
69
2.04
1.64
1.5
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
16
83
1.94
1.64
1.2
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
119
955
1.26
1.64
3.2
2.7
e9/l
3.8
4.0
0.67
89
754
(3051611) Lipemic interference index of Serum or Plasma
22
127
1.74
1.64
3.3
2.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
55
394
1.41
1.64
1.8
1.7
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
5
14
3.58
1.61
1.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
26
159
1.64
1.59
1.2
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
14
70
2.01
1.59
1.5
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
8
172
0.46
1.58
5.3
4.2
u/ml
44.8
51.3
—
8
172
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
28
175
1.61
1.58
1.2
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
36
239
1.52
1.58
1.3
1.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
36
240
1.51
1.55
2.2
1.7
pmol/l
227.1
211.0
0.43
31
229
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
15
3.34
1.52
1.2
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
16
86
1.87
1.50
1.1
1.2
—
—
—
0
0
(4268621)
22
132
1.67
1.46
2.9
2.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
38
2.37
1.45
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
38
2.37
1.45
1.0
1.1
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
7
28
2.51
1.45
1.1
1.0
mg/g
6.9
9.3
—
7
28
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
28
2.51
1.45
1.0
1.0
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
5
16
3.13
1.44
1.0
1.3
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
5
16
3.13
1.44
1.0
1.3
—
—
—
0
0
(44806071)
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
9
39
2.31
1.43
3.0
2.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
24
149
1.62
1.41
1.7
2.1
mg/l
22.0
28.7
—
5
38
(3029396) Erythrocyte agglutination [Presence] in Blood
7
29
2.42
1.39
2.0
3.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
41
2.20
1.37
2.8
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
41
2.20
1.37
2.8
1.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
41
2.20
1.37
2.8
1.9
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
17
2.95
1.36
1.2
1.8
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
13
68
1.92
1.33
2.8
2.7
%
47.2
44.2
—
5
18
(3006462) Nitrate [Presence] in Urine
11
54
2.04
1.33
2.3
3.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
12
61
1.97
1.33
1.1
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
12
61
1.97
1.33
1.1
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
27
404
0.66
1.32
1.2
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
27
176
1.54
1.32
1.0
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
66
508
1.31
1.30
1.9
1.7
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
43
2.10
1.30
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
43
2.10
1.30
1.0
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
30
201
1.50
1.30
1.1
1.1
u/ml
3.0
2.6
—
10
91
(4015189)
5
18
2.78
1.28
3.4
1.7
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
18
2.78
1.28
1.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
18
2.78
1.28
1.0
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
61
466
1.32
1.27
1.6
1.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
10
48
2.09
1.27
1.0
1.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
34
235
1.46
1.27
1.1
1.1
iu/ml
4.5
2493.0
0.53
12
53
(3036071) Salmonella sp Ab [Titer] in Serum
11
55
2.01
1.27
1.2
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
35
2.29
1.27
1.4
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
286
2557
1.14
1.25
4.3
3.9
%
22.5
21.2
0.62
123
1172
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
36
2.23
1.24
1.0
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
56
1.97
1.22
1.2
1.6
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
11
56
1.97
1.22
2.7
2.7
u/ml
513.9
1597.1
1.51
11
56
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
19
2.64
1.21
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
37
2.17
1.21
1.0
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
12
64
1.88
1.18
1.2
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
14
79
1.78
1.17
1.9
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
36
257
1.41
1.16
8.1
4.9
iu/ml
239.8
577.2
—
5
29
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
35
0.00
1.15
0.0
1.3
—
6.3
—
0
28
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
40
2.00
1.12
1.0
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
161
1393
1.17
1.11
3.8
4.4
ug/l
9.5
22.9
0.94
114
1110
(40768443) Skin Pathology biopsy report
68
539
1.27
1.11
1.2
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
31
2.26
1.10
1.1
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
7
32
2.19
1.08
1.1
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
41
304
1.36
1.07
3.3
2.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
22
2.28
1.03
1.2
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
17
106
1.61
1.03
2.4
2.8
mg/l
61.8
32.9
—
10
72
(4211845)
11
60
1.84
1.03
2.3
3.4
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
13
75
1.74
1.02
1.5
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
19
122
1.56
1.02
2.5
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
289
2622
1.12
1.02
1.4
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
32
230
1.40
1.02
1.0
1.1
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
12
68
1.77
1.00
2.8
2.8
e9/l
0.1
0.1
1.12
12
68
(3032057) Clostridioides difficile [Presence] in Stool
5
23
2.18
0.98
1.2
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
45
346
1.31
0.95
1.2
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
51
1.77
0.94
1.1
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
51
1.77
0.94
1.2
1.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
20
133
1.51
0.94
1.4
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
37
1.90
0.94
3.1
3.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
37
277
1.34
0.94
4.1
1.8
nmol/l
1.0
0.7
1.99
32
232
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
27
2.23
0.93
1.0
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
35
260
1.35
0.93
1.4
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
70
1.72
0.92
3.1
2.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
195
1739
1.14
0.92
4.8
4.2
%
32.3
32.5
0.09
146
1125
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
29
2.07
0.89
4.2
2.4
umol/l
17.8
17.2
—
6
29
(3009871) Measles virus Ab [Titer] in Serum
8
43
1.86
0.87
2.0
1.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
27
195
1.39
0.86
1.3
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
64
1.72
0.86
1.5
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
22
153
1.44
0.85
1.3
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
13
80
1.63
0.84
1.5
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
33
248
1.34
0.84
1.2
1.1
u/ml
0.3
3.3
1.92
14
111
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
57
1.76
0.83
1.1
1.0
miu/ml
1713.1
1682.0
—
10
57
(40757494) Bilirubin.total [Moles/volume] in Blood
10
57
1.76
0.83
1.7
2.6
—
86.9
—
0
6
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
46
1.74
0.82
1.0
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
17
113
1.51
0.82
3.9
3.3
%
48.9
54.6
—
9
80
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
25
180
1.39
0.82
1.8
1.5
ug/l
3.4
4.9
0.42
19
160
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
44
346
1.28
0.82
1.5
1.6
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
47
1.71
0.80
1.3
1.1
iu/ml
134.6
317.0
—
8
47
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
18
122
1.48
0.80
1.1
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
31
233
1.34
0.79
1.1
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
41
321
1.28
0.79
1.6
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
48
1.67
0.78
1.1
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
66
1.67
0.78
1.5
1.3
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
12
74
1.63
0.78
1.4
1.6
—
9.2
—
0
5
(3002523) Influenza virus A Ag [Presence] in Specimen
17
245
0.69
0.77
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
17
245
0.69
0.77
1.2
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
210
1907
1.11
0.76
3.5
2.8
ug/l
0.7
0.7
0.36
134
1210
(3051387) C reactive protein [Mass/volume] in Capillary blood
24
325
0.73
0.76
5.5
3.4
mg/l
34.8
25.0
0.53
19
204
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
15
99
1.52
0.75
1.7
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
12
75
1.60
0.75
1.4
1.2
u/ml
3.4
2.7
—
7
28
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
12
75
1.60
0.75
1.1
1.9
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
54
1.67
0.74
1.3
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
38
1.85
0.73
1.4
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
29
219
1.33
0.73
1.6
1.7
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
29
220
1.32
0.71
1.1
1.1
u/ml
0.5
8.0
5.49
14
116
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
40
1.75
0.71
1.4
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
65
545
1.20
0.71
1.9
1.6
mg/l
3.1
3.3
0.10
52
365
(21494434) Karyotype in Bone marrow
16
109
1.47
0.71
1.1
1.3
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
27
1.85
0.68
3.2
1.7
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
27
1.85
0.68
3.6
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
27
1.85
0.68
1.2
1.1
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
11
69
1.60
0.68
1.0
1.2
—
1.5
—
0
17
(3008401) Mugwort IgE Ab [Units/volume] in Serum
28
214
1.31
0.67
1.1
1.1
u/ml
0.2
2.6
1.86
12
103
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
28
1.79
0.66
1.2
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
28
1.79
0.66
1.2
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
28
1.79
0.66
1.2
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
28
1.79
0.66
1.2
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
17
120
1.42
0.64
1.1
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
87
757
1.16
0.63
1.4
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
27
207
1.31
0.63
1.0
1.1
u/ml
3.5
2.4
—
8
50
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
59
497
1.19
0.63
2.6
3.8
u/ml
149.9
812.4
1.13
48
427
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
104
0.58
0.62
1.0
1.3
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
8
50
1.60
0.61
2.1
1.9
%
2.9
6.9
—
8
50
(21494814) CD8 cells/100 lymphocytes in Specimen
8
50
1.60
0.61
2.1
1.9
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
13
88
1.48
0.60
1.2
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(4306422)
24
183
1.32
0.59
1.2
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
72
1.53
0.59
1.2
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
177
1623
1.10
0.57
6.8
5.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
11
73
1.51
0.56
1.0
1.7
—
—
—
0
0
(3024263) Appearance of Synovial fluid
9
60
1.50
0.54
1.2
2.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
18
238
0.75
0.53
1.9
1.6
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
23
178
1.30
0.53
1.3
1.4
mmol/l
7.4
7.5
0.02
15
131
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
100
0.60
0.51
1.8
1.5
g/l
0.8
1.0
—
6
100
(3017704) Immunofixation for Urine
9
64
1.41
0.51
2.0
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
24
188
1.28
0.51
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
61
528
1.16
0.51
1.9
1.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
15
109
1.38
0.51
1.2
1.1
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
6
41
1.46
0.50
1.2
1.4
%
18.4
49.8
—
6
36
(3008757) Leukocyte morphology finding [Identifier] in Blood
18
137
1.32
0.47
5.3
3.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
16
120
1.34
0.46
2.2
2.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
49
1.43
0.46
1.3
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
49
1.43
0.46
1.3
1.3
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
16
121
1.33
0.44
2.1
1.3
e6/l
360520.8
72008.9
—
10
80
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
11
78
1.41
0.43
2.7
1.5
pmol/l
201.3
65.0
—
5
21
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
8
56
1.43
0.42
1.3
2.2
mg/l
9.8
9.2
—
8
47
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
93
0.64
0.42
6.5
6.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
32
1.56
0.42
1.0
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
32
1.56
0.42
1.2
1.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
32
1.56
0.42
3.0
3.8
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
32
1.56
0.42
1.0
1.2
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
5
33
1.52
0.41
1.0
1.5
—
13.9
—
0
6
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
15
0.00
0.41
0.0
1.3
—
10.7
—
0
7
(46235168) Fasting glucose [Moles/volume] in Blood
0
16
0.00
0.41
0.0
1.2
—
8.0
—
0
7
(4146454)
10
138
0.72
0.40
3.3
2.6
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
34
1.47
0.40
2.4
2.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
21
168
1.25
0.40
1.4
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
22
178
1.24
0.39
1.0
1.1
%
121.6
116.2
0.24
17
166
(3015183) Erythrocyte sedimentation rate
11
80
1.38
0.38
1.6
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
66
1.37
0.38
1.3
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
48
420
1.15
0.38
1.5
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
11
81
1.36
0.36
1.1
1.2
—
—
—
0
0
(4024509)
15
117
1.28
0.35
1.3
1.6
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
24
199
1.21
0.35
1.3
1.4
u/l
29.0
26.1
0.12
19
166
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
78
709
1.10
0.35
1.4
1.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
44
1.36
0.34
1.0
1.5
ug/l
10.8
8.4
—
6
44
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
62
557
1.12
0.34
1.5
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
14
109
1.29
0.33
1.0
1.1
nmol/l
350.6
387.3
—
9
97
(40768806) Pleura Pathology biopsy report
13
101
1.29
0.31
1.7
1.4
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
7
52
1.35
0.31
3.7
2.3
nmol/l
114.3
142.2
—
7
46
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
35
305
1.15
0.31
1.6
1.7
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
54
1.30
0.30
2.6
2.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
7
55
1.27
0.30
2.3
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
19
158
1.20
0.28
1.5
1.3
—
—
—
0
0
(44813793)
11
85
1.30
0.28
1.1
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
62
1.29
0.28
1.1
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
36
318
1.13
0.27
4.4
3.7
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
8
66
1.21
0.26
1.0
1.1
—
5.8
—
0
14
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
170
1.18
0.24
1.2
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
11
87
1.27
0.24
3.0
2.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
10
0.00
0.21
0.0
1.0
—
9.0
—
0
5
(40760409) HLA-A [Type] by High resolution
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.2
—
9.2
—
0
12
(44786800) Granulocytes/100 leukocytes in Body fluid
0
12
0.00
0.21
0.0
1.2
—
25.7
—
0
7
(40768441) Liver Pathology biopsy report
12
98
1.23
0.21
1.5
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
49
1.23
0.20
1.3
1.8
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
12
99
1.21
0.19
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
12
99
1.21
0.19
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
12
99
1.21
0.19
1.0
1.2
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
22
193
1.14
0.19
1.4
1.9
—
1560.0
—
0
6
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
27
241
1.12
0.19
1.8
1.6
—
—
—
0
0
(4035726)
133
1274
1.05
0.18
1.3
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
12
100
1.20
0.18
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
12
100
1.20
0.18
1.0
1.2
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
12
100
1.20
0.18
1.3
1.2
—
80.8
—
0
5
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
12
100
1.20
0.18
1.0
1.2
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
7
60
1.17
0.17
1.3
1.6
—
1021416.7
—
0
6
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
156
1503
1.04
0.17
1.5
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
15
129
1.16
0.17
1.2
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
17
148
1.15
0.17
1.8
1.3
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
18
158
1.14
0.16
1.1
1.1
u/ml
0.9
4.0
—
8
66
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
17
149
1.14
0.15
1.8
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
17
150
1.13
0.14
1.8
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
17
150
1.13
0.14
1.8
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
17
150
1.13
0.14
1.8
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
17
150
1.13
0.14
1.8
1.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
15
131
1.15
0.14
5.3
5.9
mg/l
11.2
11.3
0.04
15
125
(40768795) Lymph node Pathology biopsy report
13
149
0.87
0.13
1.1
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
14
159
0.88
0.13
1.2
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
23
209
1.10
0.13
1.9
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
38
356
1.07
0.12
1.2
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
14
124
1.13
0.11
1.1
2.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
21
192
1.09
0.10
3.8
2.8
u/ml
242.2
1392.7
0.39
21
184
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
115
1.13
0.10
1.8
2.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
19
173
1.10
0.10
1.3
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
44
1.14
0.10
1.2
1.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
44
1.14
0.10
1.2
1.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
45
1.11
0.09
1.0
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
47
1.06
0.09
1.6
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
34
321
1.06
0.09
1.4
1.5
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
54
1.11
0.09
1.8
2.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
27
288
0.94
0.08
2.2
2.4
ug/min
52.1
74.6
0.35
18
174
(3044242) Glucose [Moles/volume] in Arterial blood
7
64
1.09
0.08
2.0
1.7
—
—
—
0
0
(3000012) Reticulocyte production index
7
66
1.06
0.08
1.0
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
33
313
1.06
0.07
1.5
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
23
215
1.07
0.07
1.7
1.8
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
40
382
1.05
0.07
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
40
382
1.05
0.07
1.4
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
86
1.05
0.07
1.8
1.6
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
40
383
1.05
0.07
1.4
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
88
1.02
0.07
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
20
188
1.06
0.05
1.3
1.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
19
180
1.06
0.04
1.0
1.0
u/ml
1.1
3.7
—
7
67
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
20
210
0.95
0.03
1.4
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
40
411
0.97
0.03
1.4
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
80
811
0.99
0.02
1.5
1.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
39
381
1.02
0.02
1.4
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
27
263
1.03
0.01
1.2
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
45
457
0.98
0.01
1.5
1.5
—
—
—
0
0
(4281824)
18
186
0.97
0.00
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
95
1.05
0.00
1.5
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
32
315
1.02
0.00
1.5
1.4
—
—
—
0
0
(4038314)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
86
0.93
0.00
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
86
0.93
0.00
1.0
1.0
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
2.4
—
3.9
—
0
7
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
66.3
—
0
6
(3017569) Oxygen content in Arterial blood
5
51
0.98
0.00
1.8
1.7
—
—
—
0
0
(3013762) Body weight Measured
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
7
72
0.97
0.00
2.0
2.2
ug/l
2.9
4.2
—
7
62
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
10
100
1.00
0.00
1.6
1.6
mmol/l
10.1
7.6
—
5
56
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003577) Lead [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
8
0.00
0.00
0.0
10.3
—
—
—
0
0
(3035880) pH of Pleural fluid
5
53
0.94
0.00
1.0
1.4
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
1.1
—
0
5
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
5.8
—
—
—
0
0
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
18.2
—
0
6
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
6
0.00
0.00
0.0
1.2
—
7.5
—
0
6
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
67
0.90
0.00
3.5
2.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
5
52
0.96
0.00
6.0
3.4
ng/l
81.4
202.2
—
5
34
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
75
0.93
0.00
1.3
1.1
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
14.2
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
88
0.91
0.00
1.1
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_ABNORMAL_BLOOD_P_READI_WO_DIAGNOSIS – Abnormal blood-pressure reading, without diagnosis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).